Surgical

Akreos® AO Aspheric IOL

Bausch & Lomb Akreos® AO lens is the world’s first aberration-free aspheric acrylic IOL.  Unlike other IOLs it does not add further aberrations to the patient’s eye. This leaves a slight, naturally occurring positive aberration from the cornea, providing better depth of field.

It provides all your cataract patients with exceptional postoperative vision quality and contrast sensitivity.

       Akreos AO                                     Hydroport SI injector (AI-28)

Akreos® AO: Better Vision for More People

  • The Akreos AO Lens is designed to be free of spherical aberration.
  • Optical performance is unaffected by optical or anatomical decentrations or by pupil size due to uniform centre-to-edge power.1
  • More predictable and repeatable refractive outcomes with a broader patient population can be expected.

 

Akreos® AO Aberration-Free Design Helps to Enhance Depth of Field

  • The Akreos AO Lens maintains the natural positive spherical aberrations compared to aspheric aberrated IOLs
  • With its aberration-free design, Akreos AO helps to significantly improve depth of field in comparison to an aspheric aberrated IOL

 

Optimised Effectiveness Against PCO

  • The Akreos AO Lens benefits from the unique Square-Edge Technology and a 360° posterior barrier. Both features minimising cell migration following implantation.

 

Fully Single Use Injection System

  • The Akreos AO can be injected through the AI-28 injector system, enabling implantation of the Akreos AO lens through a Sub-3.0mm phaco incision.

 

 

 

1. G. Lofoco. Influence of Aspheric and Spherical IOLs on Higher-Order Aberrations and Functional Vision: Results of a Comparative Multicenter Study. ASCRS 2006.